dihexa pnb-0408 c-met hgfr activator PEPTIDE 10MG VIAL – UMBRELLA Labs HGF/c-MET pathway in cancer: from
HGF c MET pathway in cancer: from molecular characterization to clinical evidence Oncogene Dihexa (PNB 0408) C27H44N4O5 CID 125355097 PubChem dihexa chemical properties solubility stability dihexa water solubility mg ml Elzovantinib (TPX 0022) c Met inhibitor dihexa dementia Dihexa (PNB 0408) c Met HGFR Activator dihexa chemical properties solubility stability Cabozantinib hydrochloride c Met inhibitor CAS 1817759 42 4 Drug development of MET inhibitors: targeting oncogene addiction and expedience Nature Reviews Drug Discovery
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22




